R-nuucell reaches Catapult Semifinals!
R-nuucell is amongst the thirty promising start-upsin the EIT Health Catapult 2023-24 semifinals! Each year, the competition showcases Europe’s most promising life science and healthtech start-ups to leading experts and investors.
They will now receive high-quality training from experienced entrepreneurs, investors, and experts in the field. This mentorship is tailored to each start-up’s individual needs to strengthen and optimise their business plans and pitches.
